HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers.

MLA

Mo, Xiulei, et al. “HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-Cancer Immune Enhancers.” Cell Chemical Biology, vol. 26, no. 3, Mar. 2019, p. 331. EBSCOhost, https://doi.org/10.1016/j.chembiol.2018.11.011.

APA

Mo, X., Tang, C., Niu, Q., Ma, T., Du, Y., & Fu, H. (2019). HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers. Cell Chemical Biology, 26(3), 331. https://doi.org/10.1016/j.chembiol.2018.11.011

Chicago

Mo, Xiulei, Cong Tang, Qiankun Niu, Tingxuan Ma, Yuhong Du, and Haian Fu. 2019. “HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-Cancer Immune Enhancers.” Cell Chemical Biology 26 (3): 331. doi:10.1016/j.chembiol.2018.11.011.